Which antibiotics treat gonorrhea and chlamydia

Gonorrhea can be cured with the right treatment. CDC recommends a single dose of mg of intramuscular ceftriaxone.

Alternative regimens are available when ceftriaxone cannot be used to treat urogenital or rectal gonorrhea. Although medication will stop the infection, it will not repair any permanent damage done by the disease. Antimicrobial resistance in gonorrhea is of increasing concern, and successful treatment of gonorrhea is becoming more difficult.

A test-of-cure is needed days after treatment for people who are treated for a throat infection. A swab of your throat, urethra, vagina or rectum can collect bacteria that can be identified in a lab. Request an Appointment at Mayo Clinic. Share on: Facebook Twitter. Show references Gonorrhea: CDC fact sheet detailed version. Centers for Disease Control and Prevention. Accessed Sept. Ghanem KG. Clinical manifestations and diagnosis of Neisseria gonorrhoeae infection in adults and adolescents.

Office on Women's Health. Merck Manual Professional Version. Chlamydia, gonorrhea, and nongonococcal urethritis. The information contained on this Web site should not be used as a substitute for the medical care and advice of your pediatrician.

There may be variations in treatment that your pediatrician may recommend based on individual facts and circumstances. Follow Us. Back to Top. Chronic Conditions. Common Surgical Procedures. Developmental Disabilities. Emotional Problems. From Insects or Animals. All four regimens are effective for treatment of chancroid in patients with or without HIV.

Of note, several isolates of chancroid with intermediate resistance to either ciprofloxacin or erythromycin have been reported. Patients should be re-examined within three to seven days after initiation of therapy.

Symptomatic improvement should be reported within three days if treatment is successful. Ceftriaxone Rocephin. Ciprofloxacin Cipro. Erythromycin base. Doxycycline Vibramycin. Erythromycin base plus during pregnancy. Famciclovir Famvir. Valacyclovir Valtrex. Reprinted from Centers for Disease Control and Prevention.

Montvale, N. Cost to the patient will be higher, depending on prescription filling fee. Genital herpes is a recurrent, incurable viral disease. Patient counseling should include information about recurrent episodes, asymptomatic viral shedding, perinatal transmission and sexual transmission.

Episodic antiviral therapy during outbreaks may shorten the duration of the lesions, and suppressive antiviral therapy may prevent recurrences. During the first clinical episode, the goal of systemic antiviral drug therapy is to control the signs and symptoms of genital herpes.

Daily suppressive therapy is recommended for use in patients who have six or more recurrences per year. Three antiviral medications have been proved in randomized trials to provide clinical benefit in patients with genital herpes: acyclovir, valacyclovir and famciclovir.

Clinical experience with systemic acyclovir in the treatment of genital herpes has been substantial. Topical therapy is less effective than systemic therapy, and its use is not recommended. Two newer antiviral agents are valacyclovir and famciclovir. Famciclovir, a prodrug of penciclovir, also has high oral bioavailability. The safety of antiviral therapy in pregnant women has not been established, but extensive clinical experience with acyclovir has been reassuring.

Severe or first-episode disease that occurs during pregnancy may be treated with acyclovir. However, the routine administration of antiviral agents in pregnant women with uncomplicated or recurrent genital herpes is not recommended. Syphilis is a systemic disease caused by the sexual transmission of Treponema pallidum.

It can present as primary, secondary or tertiary disease. Primary disease presents with one or more painless ulcers or chancres at the inoculation site. Secondary disease manifestations include rash and adenopathy. Cardiac, neurologic, ophthalmic, auditory or gummatous lesions characterize tertiary infections.

Latent disease may be detected by serologic testing, without the presence of signs and symptoms. Early latent disease is defined as disease acquired within the preceding year. All other cases of latent syphilis are considered late latent disease or disease of unknown duration.

The recommended treatment regimens have not changed since the CDC Guidelines. Parenteral penicillin G is still the preferred drug for treating all stages of syphilis, including disease in pregnant women. Table 1 outlines the different penicillin preparations and the proper dosages and durations of therapy, depending on the stage of syphilis at patient presentation.

Patients with early disease and penicillin allergy may be desensitized first and then treated with penicillin or treated with another recommended regimen. Patients with HIV infection require treatment with penicillin at all stages of syphilis. Treatment may be associated with the Jarisch-Herxheimer reaction. This reaction is an acute febrile illness that may occur within the first 24 hours of therapy and includes symptoms such as headache and myalgias.

Concomitant antipyretic therapy may be beneficial. Granuloma inguinale and lymphogranuloma venereum are rare in the United States. Granuloma inguinale presents as a painless, highly vascular ulcer that is caused by Calymmatobacterium granulomatis.

Patients with lymphogranuloma venereum present most often with regional lymphadenopathy; it is often a diagnosis of exclusion.